Cargando…
Interleukin-33/ Suppression of Tumorigenicity 2 in Renal Fibrosis: Emerging Roles in Prognosis and Treatment
Chronic kidney disease (CKD) is a major public health problem that affects more than 10% of the population worldwide and has a high mortality rate. Therefore, it is necessary to identify novel treatment strategies for CKD. Incidentally, renal fibrosis plays a central role in the progression of CKD t...
Autores principales: | Tan, Xiao-Yang, Jing, Hao-Yue, Ma, Yue-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761767/ https://www.ncbi.nlm.nih.gov/pubmed/35046838 http://dx.doi.org/10.3389/fphys.2021.792897 |
Ejemplares similares
-
Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022) -
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022) -
Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential
por: Huang, Fang, et al.
Publicado: (2022) -
Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis
por: Gu, Yue-Yu, et al.
Publicado: (2021) -
Correlation Profile of Suppression of Tumorigenicity 2 and/or Interleukin-33 with Biomarkers in the Adipose Tissue of Individuals with Different Metabolic States
por: Hasan, Amal, et al.
Publicado: (2020)